Founders in the earliest stages of startup life face a hefty learning curve. Just some of the core competencies you need to lock down include how to raise VC funding, recruiting the right people, finding product-market fit and building a killer go-to-market team. The list goes on and on…and on. You’ll learn about all those […]
Extra Crunch roundup: Digital health VC survey, edtech M&A, deep tech marketing, more
I had my first telehealth consultation last year, and there’s a high probability that you did, too. Since the pandemic began, consumer adoption of remote healthcare has increased 300%.
Speaking as an unvaccinated urban dweller: I’d rather speak to a nurse or doctor via my laptop than try to remain physically distanced on a bus or hailed ride traveling to/from their office.
Even after things return to
(rolls eyes) normal, if I thought there was a reliable way to receive high-quality healthcare in my living room, I’d choose it.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
Healthcare startups that had a breakout year in 2020 are poised to have an even better 2021, investors told Business Insider.
Startups, especially those focused on virtual care benefitted from being in the right place at the right time amid the global pandemic.
Business Insider interviewed dozens of venture capitalists and other private investors to learn which startups are poised to take off in 2021.
Looking back, 2020 will likely mark a sea change for healthcare startups.
Many startups saw a pandemic-sized opportunity and took advantage of new technology and newly agile hospitals and clinics to break into the notoriously difficult field.
This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
We asked healthcare and biotech venture capitalists from leading firms like Venrock and NEA to share their predictions for 2021.
2020 was a pivotal year for healthcare, shaped by the pandemic and a booming IPO market for digital health companies.
In 2021, VCs are anticipating a rough time for young startups, a big year for digital health IPOs, and increased attention for startups looking to address the healthcare industry s shortcomings.
It s difficult to imagine what 2021 has in store, after a pandemic-ravaged 2020.
But when it comes to the healthcare industry, investors are predicting certain events and trends are bound to transpire in the coming year.
Imagine a future in which earbuds could harness the power of the brain to regulate immune function. Such is the ambition of NÄsos, a startup launching out of stealth today, following months of development. The team is pioneering a new method for the treatment of rheumatoid arthritis using neuroplasticity-altering electrical fields, delivered to the target brain areas via earbuds to help regulate immune function. The company is also announcing $16.5 million in funding led by Mayfield Fund and results from its pilot clinical trial.
A dysregulated immune function, resulting in chronic inflammation, is at the root of autoimmune disorders. Existing pharmaceutical treatments require systemic delivery, risking adverse side effects from broad immunosuppression. The potential to target a pathway that enables the brain to regulate immune function, using the brainâs electrical language, could provide a new treatment option without the side-effect profile of existing therapies.